These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia. Schapel GJ; Edwards KD; Neale FC Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384 [No Abstract] [Full Text] [Related]
23. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia]. Colombo L; Monarca A; Goldberg D; Zanetta R Clin Ter; 1979 Oct; 91(2):155-71. PubMed ID: 540479 [No Abstract] [Full Text] [Related]
24. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates]. Chauvin M; Zupan M; Brechenmacher C Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia. Schapel GJ; Edwards KD J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221 [TBL] [Abstract][Full Text] [Related]
26. Creatinekinase in hyperlipoproteinemic patients treated with clofibrate. Schneider J; Mühlfellner G; Kaffarnik H Artery; 1980; 8(2):164-70. PubMed ID: 7458683 [TBL] [Abstract][Full Text] [Related]
27. Clofibrate treatment of neonatal jaundice. Erkul I; Yavuz H; Ozel A Pediatrics; 1991 Dec; 88(6):1292-4. PubMed ID: 1956756 [No Abstract] [Full Text] [Related]
28. Clofibrate myopathy: a case report and a review of the literature. Rush P; Baron M; Kapusta M Semin Arthritis Rheum; 1986 Feb; 15(3):226-9. PubMed ID: 3515563 [No Abstract] [Full Text] [Related]
29. Clofibrate-induced myopathy in the rat. Teräväinen H; Larsen A; Hillbom M Acta Neuropathol; 1977 Aug; 39(2):135-8. PubMed ID: 899740 [TBL] [Abstract][Full Text] [Related]
30. [Current data on adverse effects of clofibrate]. Wójcicki J Pol Tyg Lek; 1980 Jan; 35(1):21-3. PubMed ID: 7367314 [No Abstract] [Full Text] [Related]
31. Clofibrate, serum enzymes, and muscle pain. Smith AF; Macfie WG; Oliver MF Br Med J; 1970 Apr; 2(5701):86-8. PubMed ID: 5420239 [TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle susceptibility to clofibrate induction of lesions in rats. Okada M; Inoue Y; Ube M; Sano F; Ikeda I; Sugimoto J; Takagi S Toxicol Pathol; 2007 Jun; 35(4):517-20. PubMed ID: 17562484 [TBL] [Abstract][Full Text] [Related]
34. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats. Muroya Y; Ito O Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064 [TBL] [Abstract][Full Text] [Related]